TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Unilabs Laboratoriemedisin AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
17,252
|
14,161
|
14,533 |
| Financial expenses |
217
|
210
|
281 |
| Earnings before taxes |
1,163
|
168
|
399 |
| Total assets |
11,153
|
9,741
|
10,829 |
| Current assets |
5,995
|
3,696
|
4,328 |
| Current liabilities |
4,626
|
3,673
|
3,980 |
| Equity capital |
4,089
|
3,330
|
3,407 |
| - share capital |
30
|
32
|
34 |
| Employees (average) |
88
|
86 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.7%
|
34.2%
|
31.5% |
| Turnover per employee |
196
|
165 | |
| Profit as a percentage of turnover |
6.7%
|
1.2%
|
2.7% |
| Return on assets (ROA) |
12.4%
|
3.9%
|
6.3% |
| Current ratio |
129.6%
|
100.6%
|
108.7% |
| Return on equity (ROE) |
28.4%
|
5.0%
|
11.7% |
| Change turnover |
3,814
|
552
|
-1,944 |
| Change turnover % |
28%
|
4%
|
-12% |
| Chg. No. of employees | 2 | ||
| Chg. No. of employees % | 2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.